Filing Details

Accession Number:
0001127602-19-019895
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-24 16:25:34
Reporting Period:
2019-05-22
Accepted Time:
2019-05-24 16:25:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674993 Simon, Christopher 400 Wood Road
Braintree MA 02184
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-22 53,654 $0.00 274,645 No 4 A Direct
Common Stock Disposition 2019-05-23 24,412 $99.39 250,233 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents shares earned from performance share unit awards granted to the reporting person on June 29, 2016 and July 26, 2017 with performance periods ending on March 30, 2019, based on achievement of 80.05% and 144.31% of their respective internal financial and performance metric targets, as certified by the Compensation Committee of the Board of Directors effective May 22, 2019.
  2. This number includes unvested restricted stock units previously reported.
  3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the performance share units reported above. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.